If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWhitbread Regulatory News (WTB)

Share Price Information for Whitbread (WTB)

Share Price is delayed by 15 minutes
Get Live Data
2,369.00    0.00 (0.00%)
Bid:
2,377.00
Ask:
2,379.00
Spread: 2.00 (0.084%)
Market Cap: £3.96b
WTB Live PriceLast checked at - London Stock Exchange

Intraday Whitbread Share Chart

Directorate Change

15 Sep 2025 09:00

RNS Number : 2270Z
Whitbread PLC
15 September 2025
 

 

WHITBREAD APPOINTS NEW NON-EXECUTIVE DIRECTOR

 

Whitbread PLC is pleased to announce that Jonathan Howell is to be appointed as an Independent Non-Executive Director of the Company and Chair of the Audit Committee with effect from 1 January 2026. Horst Baier, who has been serving as interim Chair of the Audit Committee, will continue to serve on the Board and remain a member of the Audit Committee.

 

Jonathan is a seasoned executive and experienced public company director. He is Group Chief Financial Officer of The Sage Group plc, a position which he has held since 2018 and will step down from at the end of 2025. Prior to that he was Group CFO of Close Brothers Group plc for ten years. Before that he was Group CFO of The London Stock Exchange Group for nine years. The early part of Jonathan's career was at Price Waterhouse where he qualified as a chartered accountant.

 

Jonathan is a Non-Executive Director and Chair of the Audit Committee at Experian plc and previously served as a Non-Executive Director and as Chair of the Audit and Risk Committee at Sage from 2013 to 2018, before becoming the Group CFO.

 

Commenting on the appointment, Christine Hodgson, Chair of Whitbread, said:

 

"We are delighted to announce the appointment of Jonathan Howell as a Non-Executive Director. Jonathan has vast experience in both executive and non-executive roles in a variety of different companies. His international outlook and experience in technology and data-led businesses will be of great benefit to the Whitbread Board as we continue to deliver on our key strategic priorities and Five-Year Plan.

 

"On behalf of the Board, I would also like to thank Horst for his invaluable contribution as Interim Chair of the Audit Committee".

 

 

The Company confirms that there is no other information to be disclosed under the requirements of Listing Rule 6.4.8 in relation to this appointment.

 

Ends

 

For more information please contact:

Investor Relations - Whitbread investorrelations@whitbread.com

Peter Reynolds, Director of Investor Relations peter.reynolds@whitbread.com

Kirsten O'Reilly, Investor Relations Manager kirsten.oreilly@whitbread.com

Kitty Hobhouse, Investor Relations Manager kitty.hobhouse@whitbread.com

 

 

Media - Brunswick whitbread@brunswickgroup.com

Tim Danaher +44 (0) 20 7404 5959

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUUSWRVSUKAAR
Date   Source Headline
7th Jul 20262:55 pmRNSDirector/PDMR Shareholding
1st Jul 20269:16 amRNSTotal Voting Rights
18th Jun 20264:45 pmRNSResult of AGM
18th Jun 20267:00 amRNS1st Quarter Results
1st Jun 20269:22 amRNSTotal Voting Rights
29th May 202612:38 pmRNSHolding(s) in Company
22nd May 20265:02 pmRNSDirector/PDMR Shareholding
13th May 20264:46 pmRNSAnnual Financial Report
12th May 20267:34 amRNSDirector Declaration
11th May 20264:40 pmRNSDirector/PDMR Shareholding
8th May 20262:51 pmRNSDirector/PDMR Shareholding
8th May 20262:34 pmRNSHolding(s) in Company
1st May 20269:22 amRNSTotal Voting Rights
30th Apr 20267:02 amRNSOutcome of Business Review
30th Apr 20267:00 amRNSPreliminary Results Announcement
24th Apr 202611:25 amRNSHolding(s) in Company
1st Apr 20269:18 amRNSTotal Voting Rights
2nd Mar 20269:11 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSCORRECTION: Transaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20262:47 pmRNSDirector/PDMR Shareholding
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 202610:34 amRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:37 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.